mystery
10-09-08, 12:28 AM
I am looking for any information or papers on Desoxyn's mechanism of action. I'm most interested in how the effects should be different from dextroamphetamine. This is the gist of this post, and below is more detail in case you are interested.
Right now, I have some poorly developed theories. Based on information Contrapunctus (http://www.addforums.com/forums/member.php?u=26831) posted, it seems that desoxyn is extremely potent in ability to release dopamine into the synaptic cleft. Supposedly much more potent for dopamine release than dextroamphetamine. Dopamine, among other things, appears to be very important for learning, especially in the prefrontal cortex.
Rags847 (http://www.addforums.com/forums/member.php?u=21945) sent me links to some papers describing the possible inability of dopamine re-uptake inhibitors to increase dopamine much in the perfrontal cortex. Supposedly, there are not many DAT transporters in the PFC. And, more interestingly, norepinephrine re-uptake inhibitors like Strattera, can increase dopamine in the PFC.
Here are the papers:
31. (http://www.psychiatrist.com/brainstorms/br6401.pdf)Neurotransmission of cognition, Part 1. (http://www.psychiatrist.com/brainstorms/br6401.pdf)Dopamine Is a Hitchhiker in Frontal Cortex: Norepinephrine Transporters Regulate Dopamine
32. Neurotransmission of cognition, Part 2. (http://www.psychiatrist.com/brainstorms/br6402.pdf)Selective NRIs Are Smart Drugs: Exploiting Regionally Selective Actions on Both Dopamine and Norepinephrine to Enhance Cognition
33. Neurotransmission of cognition, Part 3. (http://www.psychiatrist.com/brainstorms/br6403.pdf)Mechanism of Action of Selective NRIs: Both Dopamine and Norepinephrine Increase in Prefrontal Cortex
Here are some reasons I am interested:
1. I likely have a mild learning disability, and my memory is poor.
2. Number 1 appears to get worse when I have to move around, i.e., think on my feet. Dopamine is used for movement, and dopamine disorders impair movement, e.g., Parkinson's disease.
3. I respond somewhat to a low dose of dextroamphetamine, but a larger dose that could possibly release dopamine will make me very anxious.
4. There may be no other substance that can compare in dopamine increasing ability in the PFC which could result in drastically improved cognition and learning for me.
5. Methamphetamine appears to enhance BondedCasinos (http://www.addforums.com/forums/member.php?u=26715) learning abilities based on his posts.
6. Strattera (which can increase dopamine in the PFC per the above papers) may cause too many side effects based on my limited experience with it.
7. If I have to jump through countless hoops, visit many doctors, and spend possibly many hundreds of dollars, then I'd like more info. Illegally obtaining it is counterintuitive to my goals, and I need to think ahead about the possibility of addiction.
Right now, I have some poorly developed theories. Based on information Contrapunctus (http://www.addforums.com/forums/member.php?u=26831) posted, it seems that desoxyn is extremely potent in ability to release dopamine into the synaptic cleft. Supposedly much more potent for dopamine release than dextroamphetamine. Dopamine, among other things, appears to be very important for learning, especially in the prefrontal cortex.
Rags847 (http://www.addforums.com/forums/member.php?u=21945) sent me links to some papers describing the possible inability of dopamine re-uptake inhibitors to increase dopamine much in the perfrontal cortex. Supposedly, there are not many DAT transporters in the PFC. And, more interestingly, norepinephrine re-uptake inhibitors like Strattera, can increase dopamine in the PFC.
Here are the papers:
31. (http://www.psychiatrist.com/brainstorms/br6401.pdf)Neurotransmission of cognition, Part 1. (http://www.psychiatrist.com/brainstorms/br6401.pdf)Dopamine Is a Hitchhiker in Frontal Cortex: Norepinephrine Transporters Regulate Dopamine
32. Neurotransmission of cognition, Part 2. (http://www.psychiatrist.com/brainstorms/br6402.pdf)Selective NRIs Are Smart Drugs: Exploiting Regionally Selective Actions on Both Dopamine and Norepinephrine to Enhance Cognition
33. Neurotransmission of cognition, Part 3. (http://www.psychiatrist.com/brainstorms/br6403.pdf)Mechanism of Action of Selective NRIs: Both Dopamine and Norepinephrine Increase in Prefrontal Cortex
Here are some reasons I am interested:
1. I likely have a mild learning disability, and my memory is poor.
2. Number 1 appears to get worse when I have to move around, i.e., think on my feet. Dopamine is used for movement, and dopamine disorders impair movement, e.g., Parkinson's disease.
3. I respond somewhat to a low dose of dextroamphetamine, but a larger dose that could possibly release dopamine will make me very anxious.
4. There may be no other substance that can compare in dopamine increasing ability in the PFC which could result in drastically improved cognition and learning for me.
5. Methamphetamine appears to enhance BondedCasinos (http://www.addforums.com/forums/member.php?u=26715) learning abilities based on his posts.
6. Strattera (which can increase dopamine in the PFC per the above papers) may cause too many side effects based on my limited experience with it.
7. If I have to jump through countless hoops, visit many doctors, and spend possibly many hundreds of dollars, then I'd like more info. Illegally obtaining it is counterintuitive to my goals, and I need to think ahead about the possibility of addiction.